Pfizer CEO calls US drug price plan ‘negotiation with a gun to your head’:
'It is not negotiation at all. It is price setting,' says Pfizer CEO Albert ...
rappler.com/business/pfizer-ceo-albert-bourla-reaction-united-states-drug-pricing-reform/
Photo: rappler.com · view article
Bourla Criticizes Planned US Drug-Price NegotiationsPfizer’s chief expects lawsuits and doubts they will prevent new prices from taking effect in 2026.
Key FactsMay 13, 2023 · Reading time: ~45 sec.
Summary created with AI assistance · Source: rappler.com
Summary created with AI assistance · Source: rappler.com
- Albert Bourla called the Medicare pricing plan coerced price-setting; the law aims to save $25 billion by 2031.
- He expects manufacturers to sue but is unsure whether litigation could prevent new prices taking effect in 2026.
- Likely early negotiation drugs include Pfizer’s Ibrance and Eliquis, which Pfizer shares with Bristol Myers Squibb.
- CMS said it would issue revised implementation guidance in summer 2023 after reviewing submitted comments.
It is not negotiation at all. It is price setting.— Albert Bourla, Pfizer CEO; at a Reuters newsmaker event commenting on the US drug price negotiation plan.
Story Details
| Last Updated | |
| Total Articles | 13 |
Main Topics
News on this topic
Pfizer CEO calls US drug price plan 'negotiation with a gun to your head': Pfizer Inc (PFE.N) Chief Executive Albert Bourla called U.S. plans to negotiate drug ...
reuters.com/business/healthcare-pharmaceuticals/pfizer-pouring-covid-profits-into-cancer-battle-ceo-bourla-says-2023-05-11/
Watch our interview with Pfizer CEO Albert Bourla, who will discuss the company’s next era as it launches new treatments while balancing the call for better ... Show more
Reuters Newsmaker Interview with Albert Bourla
Reuters Newsmaker Interview with Albert Bourla
Pfizer CEO calls US drug price plan ‘negotiation with a gun to your head’: 'It is not negotiation at all. It is price setting,' says Pfizer CEO Albert ...
rappler.com/business/pfizer-ceo-albert-bourla-reaction-united-states-drug-pricing-reform/
More articles on this subject
Previous
Pfizer CEO says Medicare will likely face legal action over drug price negotiations
cnbc.com/2023/05/11/pfizer-medicare-could-face-legal-action-over-drug-price-negotiations.html
Reuters Newsmaker Interview with Albert Bourla: Reuters Newsmaker Interview with Albert Bourla - - Thursday, May 11, 2023
events.reutersevents.com/reuters/newsmaker/albertbourla
Next
Similar to This
Previous
Zuckerberg, Bourla among CEOs to attend Trump's state dinner for Xi, sources say: Pfizer CEO Albert Bourla and Meta Platforms chief Mark Zuckerberg are the ...
reuters.com/world/china/pfizer-ceo-bourla-plans-attend-white-house-state-dinner-chinas-xi-source-says-2026-09-22/
STAT Jun 12
Trump administration revisits policy to close Medicare drug price negotiation loophole
statnews.com/2026/06/12/medicare-drug-price-negotiation-loophole-proposed-rule/
Paid articlePaywall STAT May 30
Pharmalittle: We're reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more
statnews.com/pharmalot/2026/05/29/pharmalittle-were-reading-about-replimune-drug-getting-third-try-at-fda-approval-a-pfizer-deal-in-china-and-more/
Paid articlePaywall STAT Apr 29
Pharmalittle: We’re reading about the FDA speeding up trials, a Supreme Court hearing on ‘skinny labels,’ and more
statnews.com/pharmalot/2026/04/29/fda-plan-to-speed-clinical-trials-supreme-court-skinny-labels/
Paid articlePaywall
Romania Insider Apr 20
Romania seeks to swap EUR 600 mln Pfizer debt for medicines: Romania is negotiating with US pharmaceutical group Pfizer to convert a EUR 600 million payment ...
romania-insider.com/romania-pfizer-medicines-april-2026
Pharma tariffs force biotech to weigh price deals: Smaller companies don't have the resources of a Pfizer or Merck to make price cuts or domestic manufacturing ...
axios.com/2026/04/13/pharma-tariffs-trump-pressure-biotech-deals
Marksans Pharma jumps 8% on USFDA nod for cough relief drug: Marksans Pharma Share Price: Stock surges 7.9% after USFDA approves Benzonatate Capsules 100mg and ...
business-standard.com/markets/news/marksans-pharma-jumps-8-percent-on-usfda-nod-for-cough-relief-drug-126040100501_1.html
Surprising quarterly figures: Pharma giants disappoint investors despite growth: Merck and Pfizer surprise with quarterly figures. But strong growth at Keytruda ...
wallstreet-online.de/nachricht/20448941-aktien-fallen-trotzdem-ueberraschende-quartalszahlen-pharma-riesen-enttaeuschen-anleger-trotz-wachstum
Pfizer CEO Albert Bourla’s best leadership advice: Being optimistic is better than being right
fortune.com/2026/01/31/pfizer-ceo-albert-bourlas-best-leadership-advice-being-optimistic-is-better-than-being-right/
Paid articlePaywall‘We’ll save the world from cancer’: Inside Pfizer CEO’s $23 billion post‑COVID bet on oncology
fortune.com/2026/01/30/pfizer-ceo-save-world-cancer-covid-19-oncology-investment-interview/
Paid articlePaywall
Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra: SAN FRANCISCO, Jan 12 (Reuters) - Pfizer is preparing for a consumer market for ...
finance.yahoo.com/news/pfizer-ceo-plans-soaring-consumer-234253473.html
Fighting Cancer With 'Smart Bombs.' What New Treatments Mean For Wall Street.: A new form of precision medicine could oust traditional chemotherapy ...
investors.com/news/technology/biotech-stocks-antibody-drug-conjugates-adcs-cancer-treatment-chemotherapy/
President announces TrumpRx website for drugs, and pricing deal with Pfizer: The Trump administration says it is making deals with drug companies to lower prices ...
npr.org/sections/shots-health-news/2025/09/30/nx-s1-5558432/drug-prices-trumprx-pfizer
U.S. Drugmakers Warn White House of Chaos as Trump Weighs Curbs on China: Behind the scenes, major pharmaceutical companies and Trump-tied billionaires are ...
nytimes.com/2025/09/10/business/trump-medicines-china-biotech.html
No drug price pledges by Pfizer, others in talks with US government, Pfizer CEO says
reuters.com/business/healthcare-pharmaceuticals/pfizer-ceo-says-no-commitments-made-meetings-with-us-governments-drug-pricing-2025-06-09/
Pfizer CEO: HHS claims of ‘concealed safety concerns’ on mRNA vaccines are ‘completely inaccurate’
cnn.com/2025/05/30/health/pfizer-bourla-vaccines
Next